Skip to main content

Table 2 Duration and dose by route of treatment; ITT population

From: Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial

Parameter

(n = 43)

Intravenous anidulafungin

Oral voriconazole

Duration, daysa

  

  n

43

14

  Mean ± SD

11.0 (± 6.81)

12.6 (± 8.89)

  Median

10.0

10.0

  Range

1.0–37.0

4.0–38.0

Dose, mg/day

  

  n

43

14

  Mean ± SD

117.8 (± 24.09)

364.8 (± 72.86)

  Median

110.0

400.0

  Range

102.7–200.0

193.8–400.0

  1. aIncludes only days on which any dose was taken.
  2. Abbreviations used: ITT, intent-to-treat; SD, standard deviation.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us